Human Amniotic Epithelial Stem Cells Promote Colonic Recovery in Experimental Colitis via Exosomal MiR‐23a–TNFR1–NF‐κB Signaling
Advanced Science · 2024-11 · 11 (44)
DOI: 10.1002/advs.202401429 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 08.10.2024. Verfasst von Yaohui Kou und 16 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Cardiovascular Intervention and Regenerative Medicine of Zhejiang Province of Sir Run Run Shaw Hospital, MOE Laboratory of Biosyste…. Hauptthemen laut MEDLINE: MicroRNAs, Colitis, Disease Models, Animal, Signal Transduction. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Zhejiang Provincial Key R&D Program of China, National Key R&D Program of China, China Manned Space Flight Technology Project Chinese Space Station.
Abstract (Originalsprache)
Inflammatory bowel disease (IBD), including ulcerative colitis and Crohn's disease, manifests as chronic intestinal inflammation with debilitating symptoms, posing a significant burden on global healthcare. Moreover, current therapies primarily targeting inflammation can lead to immunosuppression‐related complications. Human amniotic epithelial stem cells (hAESCs), which exhibit low immunogenicity and ethical acceptability, have gained attention as potential therapeutics. In this study, it is demonstrated that their encapsulation in a hydrogel and administration via anal injection enhanced the colonic mucosal barrier repair in a murine colitis model induced by dextran sodium sulfate during the recovery phase. The underlying mechanism involved the release of exosomes from hAESCs enriched with microRNA‐23a‐3p, which post‐transcriptionally reduced tumor necrosis factor receptor 1 expression, suppressing the nuclear factor‐κB pathway in colonic epithelial cells, thus played a key role in inflammation. The novel approach shows potential for IBD treatment by restoring intestinal epithelial homeostasis without the immunosuppressive therapy‐associated risks. Furthermore, the approach provides an alternative strategy to target the key molecular pathways involved in inflammation and promotes intestinal barrier function using hAESCs and their secreted exosomes. Overall, this study provides key insights to effectively treat IBD, addresses the unmet needs of patients, and reduces related healthcare burden.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Cardiovascular Intervention and Regenerative Medicine of Zhejiang Province of Sir Run Run Shaw Hospital, MOE Laboratory of Biosystems Homeostasis & Protection of College of Life Sciences, Zhejiang Univ…
- College of Life Sciences-iCell Biotechnology Regenerative Biomedicine Laboratory, Zhejiang University-Lishui Joint Innovation Center for Life and Health, Lishui, Zhejiang, 323010, China.
- Eye Center the Second Affiliated Hospital, School of Medicine, Zhejiang Provincial Key Laboratory of Ophthalmology, Zhejiang Provincial Clinical Research Center for Eye Diseases, Zhejiang Provincial Engineering Institut…
- Department of Obstetrics, Women's Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, 310006, China.
- Department of General Surgery, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Liangzhu Laboratory, Zhejiang University, Hangzhou, Zhejiang, 310012, China.
ORCID-Profile: Xiyang Wei, Luyang Yu
Förderung
- Zhejiang Provincial Key R&D Program of China
- National Key R&D Program of China
- China Manned Space Flight Technology Project Chinese Space Station
- National Natural Science Foundation of China
- Fundamental Research Funds for the Central Universities of China
- National Key Research and Development Program of China
- Fundamental Research Funds for the Central Universities
Zitieren
APA
Kou, Y., Li, J., Zhu, Y., Liu, J., Ren, R., Jiang, Y., Wang, Y., Qiu, C., Zhou, J., Yang, Z., Jiang, T., Huang, J., Ren, X., Li, S., Qiu, C., Wei, X., & Yu, L. (2024). Human Amniotic Epithelial Stem Cells Promote Colonic Recovery in Experimental Colitis via Exosomal MiR‐23a–TNFR1–NF‐κB Signaling. Advanced Science, 11(44). https://doi.org/10.1002/advs.202401429
Vancouver
Kou Y, Li J, Zhu Y, Liu J, Ren R, Jiang Y, et al. Human Amniotic Epithelial Stem Cells Promote Colonic Recovery in Experimental Colitis via Exosomal MiR‐23a–TNFR1–NF‐κB Signaling. Advanced Science. 2024;11(44). doi:10.1002/advs.202401429
BibTeX
@article{Kou2024,
author = {Kou, Yaohui and Li, Jinying and Zhu, Yingyi and Liu, Jia and Ren, Ruizhe and Jiang, Yuanqing and Wang, Yunyun and Qiu, Chen and Zhou, Jiayi and Yang, Zhuoheng and Jiang, Tuoying and Huang, Jianan and Ren, Xiangyi and Li, Shiguang and Qiu, Cong and Wei, Xiyang and Yu, Luyang},
title = {Human Amniotic Epithelial Stem Cells Promote Colonic Recovery in Experimental Colitis via Exosomal MiR‐23a–TNFR1–NF‐κB Signaling},
journal = {Advanced Science},
year = {2024},
volume = {11},
number = {44},
doi = {10.1002/advs.202401429}
}
EUVIMED